SCHEMBL8156282

SCHEMBL8156282

CN1CCN(c2nc(N(C)C)ncc2Oc2ccc(Cl)cc2)CC1.Clc1ccc(Oc2cnc(Nc3ccccc3)nc2N2CCOCC2)cc1.O=C(Nc1ccccc1)Nc1ncc(Oc2ccc(Cl)cc2)c(N2CCOCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 10/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
PIK3R1 P27986 2/20 0.43
PIK3CA P42336 2/20 0.43
FLT3 P36888 2/20 0.42
JAK2 O60674 2/20 0.42
MAP3K7 O43318 2/20 0.42
MAP2K1 Q02750 2/20 0.42
CSF1R P07333 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
MAPK1 P28482 1/20 0.41
EGFR P00533 2/20 0.41
FGFR1 P11362 1/20 0.40
SRC P12931 1/20 0.40
BLK P51451 1/20 0.40
BMX P51813 1/20 0.40
JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712473 0.86 MTOR (0.56) MTORSMN1; SMN2PIK3R1PIK3CA
SCHEMBL7708452 0.81 SMN1; SMN2 (0.53) SMN1; SMN2FLT3MAPK1
SCHEMBL7714490 0.81 ALK (0.53) EGFR
SCHEMBL7714260 0.77 HRH4 (0.51) SMN1; SMN2
SCHEMBL8137805 0.77 ALK (0.51) SMN1; SMN2FLT3MAP3K7MAP2K1EGFR
SCHEMBL7716616 0.73 MEN1 (0.49) SMN1; SMN2FLT3
SCHEMBL7714114 0.72 HTR2A (0.48) SMN1; SMN2MAPK1EGFRSRC
SCHEMBL7708460 0.71 KMT2A (0.54) MTORMAPK1
SCHEMBL7714712 0.71 KMT2A (0.54) MTORMAPK1
SCHEMBL7714132 0.69 HRH4 (0.53) FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed